We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Indian drugmaker Aurobindo Pharma has announced that South Africa's Medicines Control Council has inspected the company's facility in Hyderabad, India, and found it to be in compliance with current good manufacturing practices.
Eli Lilly's chairman and CEO, Sidney Taurel, is in favor of a Japan-U.S. economic integration agreement and urges private groups to help lay the groundwork for such a free-trade deal.
A new vaccine against bird flu being developed by an Australian company is a step closer with the announcement that CDC Atlanta will conduct pre-clinical trials on a candidate vaccine developed by Melbourne biotechnology company BioDiem and Dutch company Akzo Nobel's Nobilon.
Japanese seasoning maker Ajinomoto Co. said on Thursday it has agreed to give exclusive global rights to develop and sell its experimental diabetes drug and related compounds to a unit of Daiichi Sankyo Co.
The Cabinet-level Department of Health (DOH) unveiled a set of rules governing the ties between medical doctors and pharmaceutical companies, under which the former are banned from taking gifts from the latter in the form of cash or vouchers.
The World Health Organization urged influenza vaccine makers to use newer strains of virus when making vaccine to protect against H5N1 avian flu, saying the evolution of the microbe has led to increased variety in circulating strains.
Pfizer Inc said that a Norwegian court decision has no practical effect on the company's ability to protect Lipitor from the launch of a competitor generic product in Norway by Ranbaxy.
Swiss pharmaceutical company Novartis AG Wednesday said it received European Union approval to sell Exjade, a treatment for people with excess iron in their bloodstream.